CD8A and neoplasm: 4T1 tumor-bearing mice were treated with a-TEA-Lys in the presence or absence of aPD-1 and then 7 days post-treatment, tumors were harvested and CD4+ and CD8+ T cell responses were evaluated by flow cytometry (Figures 1D-F).